Novartis $2 Million Gene Therapy for Rare Disorder is World’s Most Expensive Drug
Novartis has got the U.S. approval for Zolgensma drug for the treatment of spinal solid decay (SMA), the main hereditary ...
Novartis has got the U.S. approval for Zolgensma drug for the treatment of spinal solid decay (SMA), the main hereditary ...
The U.S. Food and Drug Administration (FDA) has approved Mayzent tablets (siponimod) by Novartis for the treatment of Multiple Sclerosis ...
US FDA (Food and Drug Administration) has approved Egaten® (triclabendazole) for the treatment of fascioliasis. It can be used by ...
Plot No: 47, Rd Number 4A, adjacent to Bose Edifice, Golden Tulip Estate, Raghavendra Colony, Hyderabad, Telangana, India, 500084
Email: info@highereducationplus.com
© 2021 Higher Education Plus. All rights reserved.